weight loss drugs other than glp-1 Medication Guide: Wegovy vs Ozempic vs Saxenda Unlocking The Power of GLP-1

Accessed November 13, 2023

GCGR occupancy GCGR PET tracer [ 68 Ga]Ga-DO3A-Tuna-2 demonstrated strong liver binding in all baseline examinations (Fig

Clinical research on the FDA-approved branded versions of these active ingredients includes the STEP-1 trial, which demonstrated mean weight reduction of approximately 14.9% with semaglutide over 68 weeks, and the SURMOUNT-1 trial, which showed tirzepatide achieving 1622.5% weight reduction over 72 weeks

GLP-1 RA, GLP-1 receptor agonist

Professor Subodh Verma, Cardiac Surgeon, University of Toronto said that, The CagriSema data presented at ObesityWeek are very encouraging regarding the effects on well-known CV risk factors like high blood pressure a strong signal that warrants further investigation